Go to Top

Recent Updates

For Biotech and Pharmaceutical Companies

Looking for Financing, PR or Investor Relations Services?

We facilitate introductions to leading hedge funds who share your company's best interests and may be interested in investing in you. We also bump shoulders with some of the premier Investor Relations & PR firms in the United States. We've a track record of success which supports these relationships, and a network that feeds our success. If you have a company in need of greater visibility or capital investment, we'd like to hear from you.

Biotech News and Updates

AntriaBio (ANTB): An Opportunity

Novo Nordisk – the world ‘s largest insulin producer – and major diabetes drug manufacturers – could see BILLIONS in recurring revenue dry up as a small, California-based biotech company advances a technology that promises to change diabetes treatment.

Over $100,000,000 has been invested in developing this super-drug that threatens to make products like Sanofi’ s $6 BILLION-A-YEAR basal insulin – ‘Lantus’ – OBSOLETE.

The Company that ‘s making executives in the world’ s largest pharmaceutical firms sweat is Menlo Park, California-based ANTRIABIO, INC. (ANTB)

Here ‘s why large pharma is worried about ANTRIABIO’ s technology:


Read More

OXiGENE (OXGN): ZYBRESTAT Plus Avastin Well Tolerated in Second Interim Toxicity Analysis of a Phase 2 Trial

OXiGENE, Inc. (Nasdaq :OXGN)  is a biopharmaceutical company whose mission is finding and developing new and improved therapeutics that can deliver significant medical benefits to patients with cancer and sight-threatening eye diseases and conditions.

Read More




Biotech Stocks Reviews